日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Association of Changes in Portal Insulin with Immunometabolism During and After Hepatitis C Virus Infection

丙型肝炎病毒感染期间及之后门静脉胰岛素变化与免疫代谢的关联

Menkart, Matthew G; Oringher, Jenna L; Chakraborty, Moumita; Haddad, James A; Quinn, Gabriella M; Zhang, Grace; Townsend, Elizabeth C; Akiva, Kareen L; Scheuing, Lisa; Rai, Anjali; Rampertaap, Shakuntala; Rosenzweig, Sergio D; Koh, Christopher; Brown, Rebecca J; Umarova, Regina; Levy, Elliot B; Kleiner, David E; Ali, Rabab O; Etzion, Ohad; Afruza, Rownock; Heller, Theo

Novel proteomic signatures may indicate MRI-assessed intrahepatic fat state and changes: The DIRECT PLUS clinical trial

新型蛋白质组学特征可能指示MRI评估的肝内脂肪状态和变化:DIRECT PLUS临床试验

Goldberg, Dana T; Yaskolka Meir, Anat; Tsaban, Gal; Rinott, Ehud; Kaplan, Alon; Zelicha, Hila; Klöting, Nora; Ceglarek, Uta; Iserman, Berend; Shelef, Ilan; Rosen, Philip; Blüher, Matthias; Stumvoll, Michael; Etzion, Ohad; Stampfer, Meir J; Hu, Frank B; Shai, Iris

The bioinformatics of the finding that the hepatitis delta virus RNA editing mechanism by a conformational switch exists in genotype 7 in addition to genotype 3

生物信息学研究发现,除了基因型3之外,基因型7也存在通过构象转换进行丁型肝炎病毒RNA编辑的机制。

Zakh, Rami; Churkin, Alexander; Parr, Marina; Tuller, Tamir; Etzion, Ohad; Dahari, Harel; Barash, Danny

Impact of Universal Screening for HDV in HBV-Infected Patients on Chronic HDV Detection Rate in Israel

在以色列,对乙肝病毒感染患者进行丁型肝炎病毒普遍筛查对慢性丁型肝炎病毒检出率的影响

Yardeni, David; Cividalli, Omer; Itkowitz, Bryan; Lipnizkiy, Inna; Juma'a, Ali Abu; Abufreha, Naim; Keren-Naus, Ayelet; Eisner, Nadav; Shor, Anat Nevo; Etzion, Ohad

Taurine-conjugated bile acids and their link to hepatic S1PR2 play a significant role in hepatitis C-related liver disease

牛磺酸结合胆汁酸及其与肝脏S1PR2的联系在丙型肝炎相关肝病中起着重要作用。

Ali, Rabab O; Haddad, James A; Quinn, Gabriella M; Zhang, Grace Y; Townsend, Elizabeth; Scheuing, Lisa; Hill, Kareen L; Menkart, Matthew; Oringher, Jenna L; Umarova, Regina; Rampertaap, Shakuntala; Rosenzweig, Sergio D; Koh, Christopher; Levy, Elliot B; Kleiner, David E; Etzion, Ohad; Heller, Theo

Namodenoson at the Crossroad of Metabolic Dysfunction-Associated Steatohepatitis and Hepatocellular Carcinoma

纳莫德诺森在代谢功能障碍相关性脂肪性肝炎和肝细胞癌的交叉领域

Etzion, Ohad; Bareket-Samish, Avital; Yardeni, David; Fishman, Pnina

Interferon alpha induces a stronger antiviral effect than interferon lambda in HBV/HDV infected humanized mice

在感染HBV/HDV的人源化小鼠中,干扰素α比干扰素λ具有更强的抗病毒作用。

Duehren, Sarah; Uchida, Takuro; Tsuge, Masataka; Hiraga, Nobuhiko; Uprichard, Susan L; Etzion, Ohad; Glenn, Jeffrey; Koh, Christopher; Heller, Theo; Cotler, Scott J; Oka, Shiro; Chayama, Kazuaki; Dahari, Harel

Treatment of chronic hepatitis D with peginterferon lambda-the phase 2 LIMT-1 clinical trial

使用聚乙二醇干扰素λ治疗慢性丁型肝炎——LIMT-1 II期临床试验

Etzion, Ohad; Hamid, Saeed; Lurie, Yoav; Gane, Edward J; Yardeni, David; Duehren, Sarah; Bader, Nimrah; Nevo-Shor, Anat; Channa, Saleh Muhammad; Cotler, Scott J; Mawani, Minaz; Parkash, Om; Dahari, Harel; Choong, Ingrid; Glenn, Jeffrey S

MELD-Na score may underestimate disease severity and risk of death in patients with metabolic dysfunction-associated steatotic liver disease (MASLD)

MELD-Na评分可能低估代谢功能障碍相关脂肪肝病(MASLD)患者的疾病严重程度和死亡风险。

Yardeni, David; Shiloh, Adi; Lipnizkiy, Inna; Nevo-Shor, Anat; Abufreha, Naim; Munteanu, Daniela; Novack, Victor; Etzion, Ohad

Comorbidities and Malignancy among NAFLD Patients Compared to the General Population, A Nation-Based Study

一项基于全国的研究比较了非酒精性脂肪性肝病患者与普通人群的合并症和恶性肿瘤情况

Abu-Freha, Naim; Cohen, Bracha; Gordon, Michal; Weissmann, Sarah; Fich, Alexander; Munteanu, Daniela; Yardeni, David; Etzion, Ohad